Brian C. DeFelice - Concepedia

Author

Brian C. DeFelice

Also Known As

BRIAN C. DEFELICE, Bill Wikoff, Brian D. DeFelice, Brian C DeFelice, Brian C. DeFelice, Brian DeFelice, DeFelice, Brian, DeFelice, Brian C.

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

University of California, Davis Chan Zuckerberg Initiative (United States)Stanford University King Abdulaziz University University of Colorado Anschutz Medical Campus

About

Brian C. DeFelice is an author at University of California, Davis specializing in medicine, systems biology, and metabolomics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.6K
2	Biochemistry	3	3	1.4K
3	Engineering	2	2	33
4	Health Sciences	2	2	44
5	Natural Sciences	2	2	78

Brian C. DeFelice

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
LipidBlast in silico tandem mass spectrometry database for lipid identification Tobias Kind, Kwang‐Hyeon Liu, Do Yup Lee, Nature Methods Lipid AnalysisBiochemistryMedicineMass SpectrometryAnalytical Chemistry	2013	961
A metabolomics pipeline for the mechanistic interrogation of the gut microbiome Shuo Han, Will Van Treuren, Curt R. Fischer, Nature DysbiosisBiochemistryMetabolomics PipelineMedicineMicrobiota	2021	394
Mass Spectral Feature List Optimizer (MS-FLO): A Tool To Minimize False Positive Peak Reports in Untargeted Liquid Chromatography–Mass Spectroscopy (LC-MS) Data Processing Brian C. DeFelice, Sajjan S. Mehta, Stephanie Samra, Analytical Chemistry	2017	179
Chronic, Intermittent Microdoses of the Psychedelic <i>N</i> , <i>N</i> -Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents Lindsay P. Cameron, Charlie J. Benson, Brian C. DeFelice, ACS Chemical Neuroscience	2019	159
Diacetylspermine Is a Novel Prediagnostic Serum Biomarker for Non–Small-Cell Lung Cancer and Has Additive Performance With Pro-Surfactant Protein B William R. Wikoff, Samir Hanash, Brian C. DeFelice, Journal of Clinical Oncology	2015	103
Metabolomic Markers of Altered Nucleotide Metabolism in Early Stage Adenocarcinoma William R. Wikoff, Dmitry Grapov, Johannes F. Fahrmann, Cancer Prevention Research	2015	101
Proteomic profiling of lung adenocarcinoma indicates heightened DNA repair, antioxidant mechanisms and identifies LASP1 as a potential negative predictor of survival Johannes F. Fahrmann, Dmitry Grapov, Brett S. Phinney, Clinical Proteomics	2016	67
Investigation of Metabolomic Blood Biomarkers for Detection of Adenocarcinoma Lung Cancer Johannes F. Fahrmann, Kyoungmi Kim, Brian C. DeFelice, Cancer Epidemiology Biomarkers & Prevention	2015	66
Early PQQ supplementation has persistent long‐term protective effects on developmental programming of hepatic lipotoxicity and inflammation in obese mice Karen R. Jonscher, Michael S. Stewart, Alba Alfonso‐García, The FASEB Journal	2016	65
Resource competition predicts assembly of gut bacterial communities in vitro Po-Yi Ho, Taylor H. Nguyen, Juan M. Sánchez, Nature Microbiology BiologyMicrobial DiversityDysbiosisMedicineMicrobial Ecology	2024	63

Page 1